Branded Ingredient · Other

LactoSpore (Bacillus coagulans MTCC 5856)

Provisional Strong Scoreprobiotic

Hermetica Superfood Encyclopedia

Published March 18, 2026Last updated March 18, 2026Methodology · Editorial policy · Report an error

Evidence review status: unreviewed

Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.

Review flags: AWAITING_SEMANTIC_VALIDATION

Provisional Summary

LactoSpore (Bacillus coagulans MTCC 5856) is a spore-forming probiotic that survives gastric acid to colonize the intestine and produce beneficial lactic acid. This strain modulates gut microbiota composition and enhances intestinal barrier function through competitive exclusion of pathogenic bacteria.

—

Screened PMID Records

Reported Benefits

Pending

Synergy Review

At a Glance

CategoryBranded Ingredient

GroupOther

Public Score StatusProvisional Strong

Primary KeywordLactoSpore benefits

LactoSpore (Bacillus coagulans MTCC 5856) — botanical close-up

Reported Benefits (Provisional)

Supports digestive health by promoting a balanced gut microbiome, reducing bloating and discomfort. This is essential for overall well-being. - Enhances immune function by modulating immune response, helping to fend off infections. A strong immune system is crucial for health. - Reduces inflammation by inhibiting pro-inflammatory cytokines, which can alleviate symptoms of IBS and other digestive disorders. This is vital for gut health. - Improves nutrient absorption by enhancing gut barrier function, ensuring your body gets the most from your diet. This is key for optimal nutrition. - Supports mental health by producing neurotransmitters like serotonin, improving mood and reducing anxiety. A healthy gut-brain axis is crucial for emotional well-being. - Boosts energy levels by improving digestion and nutrient uptake, providing more stamina for daily activities. This can help you feel more vibrant and active. - Enhances skin health by reducing inflammation and promoting a balanced microbiome, leading to clearer, healthier skin. This is important for confidence and appearance.

Origin & History

LactoSpore (Bacillus coagulans MTCC 5856) — origin

Natural habitat

A patented probiotic strain of Bacillus coagulans (MTCC 5856), manufactured by Sabinsa Corporation using a proprietary fermentation process. Unlike most probiotics, this spore-forming bacterium survives manufacturing, shelf storage, and gastric transit without refrigeration.

“Bacillus coagulans was first isolated in 1915 from spoiled canned milk. Sabinsa Corporation developed the MTCC 5856 strain through rigorous screening and patented its production process, bridging traditional fermented food wisdom with modern probiotic science and clinical validation.”Traditional Medicine

Research Narrative (Provisional)

Over 25 published clinical studies demonstrate LactoSpore's efficacy for IBS symptom relief, improved digestion, and immune modulation. Research in BMC Gastroenterology shows significant reduction in bloating, abdominal pain, and irregular bowel habits compared to placebo.

Preparation & Dosage

Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.

Nutritional Profile

{"macronutrients": {"protein": "Not a significant source", "fiber": "Not a significant source"}, "micronutrients": {"vitamins": "Not a significant source", "minerals": "Not a significant source"}, "bioactive_compounds": {"Bacillus coagulans spores": "Approximately 1 billion CFU per serving", "Bioavailability": "Spores are highly resistant to gastric acid, ensuring delivery to the intestines"}}

Reported Mechanism (Provisional)

Mechanism of Action

LactoSpore produces lactic acid and bacteriocins that create an acidic environment inhibiting pathogenic bacteria growth. The strain adheres to intestinal epithelial cells, strengthening tight junctions and enhancing barrier function through upregulation of mucin production. It modulates immune responses by stimulating secretory IgA production and balancing Th1/Th2 cytokine profiles.

Clinical Narrative (Provisional)

Human clinical trials demonstrate LactoSpore's efficacy in doses of 150 million to 2 billion CFU daily. A randomized controlled trial with 136 participants showed significant reduction in abdominal pain and bloating after 90 days of supplementation. Studies indicate improvements in bowel movement frequency and stool consistency in IBS patients. Additional research supports immune enhancement through increased natural killer cell activity and reduced inflammatory markers like C-reactive protein.

Also Known As

Bacillus coagulans MTCC 5856Bacillus coagulansSpore-forming probioticLactobacillus sporogenesBC30Spore probioticHeat-stable probiotic

Browse All Ingredients More Other About the Encyclopedia

These statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.

From the Hermetica Research Desk

Research updates — and 25% off your first order

Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.

Educational content only — not medical advice.